1. Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information. (23rd January 2018) Authors: Minetto, Paola; Guolo, Fabio; Clavio, Marino; Kunkl, Annalisa; Colombo, Nicoletta; Carminati, Enrico; Fugazza, Giuseppina; Matarese, Simona; Guardo, Daniela; Ballerini, Filippo; Di Grazia, Carmen; Raiola, Anna M.; Cagnetta, Antonia; Cea, Michele; Miglino, Maurizio; Lemoli, Roberto M.; Gobbi, Marco Journal: British journal of haematology Issue: Volume 184:Number 3(2019) Page Start: 457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗